SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Valiant Organics Ltd (VALIANTORG)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 540145 NSE: VALIANTORG Chemicals | Small Cap | Valiant Organics Share Price

₹279.95 4.95 (1.80%)

As on 02-Jul'26 16:59

Valiant Organics Ltd (VALIANTORG)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 540145 NSE: VALIANTORG Chemicals | Small Cap | Valiant Organics Share Price

₹279.95 4.95 (1.80%)

As on 02-Jul'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹785 Cr.
Current Price
₹280
52-Week Low / High
₹195 / 433
TTM EPS
₹11.9
TTM Sales
₹739 Cr.
Book Value per Share
₹270.9
P/E Ratio
23.61
Higher than its 5-year historical median
Industry PE
52.9
Price to Book (P/B)
1.03
Lower than its 5-year historical median
Price to Sales (P/S)
1.06
Lower than its 5-year historical median
EV/EBITDA
10.89
Lower than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
-0.47%
Underperforms industry median
Return on Capital Employed (ROCE)
2.63%
Underperforms industry median
Return on Assets (ROA)
-0.28%
Operating Profit Margin
7.5%
Net Profit Margin
-0.48%
Gross Profit Margin
5.4%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
-0.59%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
41.53%
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
37.89%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹731 Cr.
Equity
₹28 Cr.
Face Value
₹10
All Time Low / High
₹132.00 / 1925.50

Valiant Organics stock performance

Key Ratios
mw4me loader

Check Before You Invest

Quality

Locked
Login to view analysis.

Valuation

Locked
Login to view analysis.

Price Trend

Locked
Login to view analysis.
Q.1 Is Valiant Organics Ltd a good quality company?
Valiant Organics Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Valiant Organics Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Valiant Organics Ltd vs industry peers?
Valiant Organics Ltd revenue CAGR is 1.27%, compared to the industry median CAGR of 7.53%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Valiant Organics Ltd?
Promoters hold 37.89% of the Valiant Organics Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Valiant Organics Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of -29.87% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Valiant Organics Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 0%0%0%51.3%39.4%30.7%21.7%15.3%0.8%2.6%-
Value Creation
Index
NANANA2.71.81.20.60.1-0.9-0.8-

Growth Parameters

Sales 0006926757551,1531,052723719739
Sales YoY Gr.-NANANA-2.5%11.8%52.8%-8.8%-31.3%-0.6%-
Adj EPS 00011250.442.34231.3-3.1-1.711.9
YoY Gr.-NANANA-55%-16.1%-0.9%-25.4%-110%NA-
BVPS (₹) 000213.9158.8184.8225.7253.4264.2258.9270.9
Adj Net
Profit
00013112211511485-8.6-4.833
Cash Flow from Ops. 00076161115-30.82388456.4-
Debt/CF from Ops. 0001.10.91.8-11.81.13.14.4-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NA1.3%-14.6%-0.6%
Adj EPS NA-150.8%-134.4%NA
BVPSNA10.3%4.7%-2%
Share Price - -29% -20% -32.3%

Key Financial Parameters

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
00050.737.825.820.413.1-1.2-0.74.5
Op. Profit
Mgn %
00026.226.827.217.815.75.27.511.9
Net Profit
Mgn %
00017.318.517.411.29.5-1.2-0.64.5
Debt to
Equity
0000.30.40.40.60.40.40.30.1
Working Cap
Days
000012012412116221819777
Cash Conv.
Cycle
0000403460817951-6

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales6926757551,1531,052723719
Operating Expenses + 512494550948888685665
Manufacturing Costs806178112110115117
Material Costs394393402762678476457
Employee Cost 18232937464945
Other Costs 20184037534546
Operating Profit 1801812052051643854
Operating Profit Margin (%) 26.0%26.7%27.2%17.8%15.6%5.2%7.4%
Other Income + 96678109
Exceptional Items 00005-30
Interest 4356111624
Depreciation 14162130293536
Profit Before Tax 171168185176137-92
Tax 5042544835-06
Profit After Tax 121126131128103-8-3
PAT Margin (%) 17.5%18.7%17.3%11.1%9.8%-1.2%-0.5%
Adjusted EPS (₹)113.651.042.241.732.5-3.0-1.3
Dividend Payout Ratio (%)5.30%10.80%11.90%8.40%3.10%0%0%

Valuation of Valiant Organics - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 251388503613689728725
Share Capital 6142828282828
Reserves 245374475586661701697
Debt +77125185328229222227
Long Term Debt448475106717451
Short Term Debt3341110222158147176
Minority Interest12136365100
Trade Payables7488107131166207149
Others Liabilities 355575841069182
Total Liabilities 4486698761,1921,2391,2481,183

Fixed Assets

Net Fixed Assets +150276510543670643657
Gross Block229371625656813800849
Accumulated Depreciation8095116113143157192
CWIP 6612946112718666
Investments 122368419994
Inventories48457211412611489
Trade Receivables141133157321254209177
Cash Equivalents 4133145848
Others Assets 28515449689393
Total Assets 4486698761,1921,2391,2481,183

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 76161115-312388456
PBT 171168185176137-92
Adjustment 12122636404256
Changes in Working Capital -6022-49-2018954-2
Tax Paid -47-42-47-42-28-30
Cash Flow From Investing Activity + -88-184-159-124-143-65-21
Capex -89-205-171-121-115-65-29
Net Investments -223120-33-16
Others 2-21-3502
Cash Flow From Financing Activity + 12749167-112-23-32
Net Proceeds from Shares 00023000
Net Proceeds from Borrowing 0471463-3515-23
Interest Paid -4-1-5-6-11-19-24
Dividend Paid -10-26-70-1200
Others 1574786-54-1915
Net Cash Flow -115512-17-44

Financial Ratio

PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)48.3339.6529.4922.9515.77-1.19-0.47
ROCE (%)51.2539.430.6821.6615.280.792.63
Asset Turnover Ratio1.541.210.981.120.870.580.59
PAT to CFO Conversion(x)0.631.280.88-0.242.31N/AN/A
Working Capital Days
Receivable Days74.5074.107075.6099.8011798.10
Inventory Days25.3025.1028.3029.4041.6060.7051.60
Payable Days68.9075.3088.5057.1079.90143142.20

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.210.210.210.210.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Valiant Organics Ltd FAQs

The current trading price of Valiant Organics on 02-Jul-2026 16:59 is ₹279.9.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jul-2026 the market cap of Valiant Organics stood at ₹784.8 Cr

The latest P/E ratio of Valiant Organics as of 01-Jul-2026 is 22.84.

The latest P/B ratio of Valiant Organics as of 01-Jul-2026 is 1.13.

The 52-week high of Valiant Organics is ₹432.5 and the 52-week low is ₹195.2.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Valiant Organics is ₹738 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Valiant Organics Ltd is a average quality company.

The key valuation ratios of Valiant Organics Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Valiant Organics Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Valiant Organics Ltd

The company was incorporated as Valiant Organics Private Limited on February 16, 2005 under the Companies Act, 1956 and having its Registered Office in Mumbai, Maharashtra. Subsequently, the status of the company was changed to a public limited company and the name of the company was changed to Valiant Organics Limited vide special resolution dated November 26, 2014. A fresh Certificate of Incorporation consequent upon change of name was issued on July 31, 2015 by the Registrar of Companies, Mumbai in Maharashtra.

The company’s factory is well equipped with latest technology and advanced instruments in order to meet the international standards of quality which is well accepted not only by Indian customers, but also by its overseas customers in Europe, United States of America and Asia. It also offers customised specification of Chlorophenols as per the customer needs. The company’s manufacturing unit is strategically located at Sarigam in UmbergaonTaluka in Valsad District which is approximately at a distance of 180 kms from its main export port - NhavaSheva Port (JNPT) and approximately 155 kms from its office in Mumbai.

Over the years the company has built its goodwill amongst its customers and export markets and the demand for its products are more than its supply capacity, hence, it begun the process of applying with the government agencies to augment its production capacities upto 21,600 metric tonnes over the next few years in a phased manner. These expansion activities would be financed through its owned Net worth and internal accruals or certain amount of banking facilities or a combination of the same.It operates a single location manufacturing facility at Sarigam Industrial Estate having an installed capacity of 4,800 metric tonnes per annum.

Business area of the company

The company is a chemical manufacturing company with focus on manufacturing and marketing of different types of chlorophenol which is a chemical which has several applications mainly into agro-chemical industry, pharmaceutical industry, dyes industry, manufacturing of cosmetics and veterinary drugs.

Major Events

  • 2005: Incorporation as Private Limited Company.
  • 2005: Acquired assets and business of Valiant Chemical Corporation (partnership firm).
  • 2008: Explored US overseas markets by commencing exports.
  • 2013: Acquired additional plots, namely Plot No. 752, 753 and 754 at Sarigam.
  • 2013: Increase in installed capacity from 3000 MTPA to 4800 MTPA.
  • 2014: Explored Japan overseas markets by commencing exports.
  • 2015: Converted into a Public Limited Company.
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: